Cost-benefit analysis of minimally invasive treatment for hypertensive intracerebral hemorrhage based on health economics
10.3969/j.issn.1002-0152.2025.07.001
- VernacularTitle:基于卫生经济学的高血压脑出血微创治疗成本效益分析
- Author:
Qingzhen YUAN
1
;
Xinghua XU
1
;
Zhichao GAN
1
;
Yuxiao ZENG
1
;
Haitao JIN
1
;
Jiashu ZHANG
1
;
Xiaolei CHEN
1
Author Information
1. 解放军总医院第一医学中心神经外科(北京 100853)
- Publication Type:Journal Article
- Keywords:
Hypertensive intracerebral hemorrhage;
Minimally invasive surgery;
Health economics;
Cost-effectiveness analysis;
Insurance policy reform
- From:
Chinese Journal of Nervous and Mental Diseases
2025;51(7):385-390
- CountryChina
- Language:Chinese
-
Abstract:
This article is to evaluate the clinical outcomes and health economics of minimally invasive surgery for hypertensive intracerebral hemorrhage(HICH).This review systematically compares clinical efficacy and economic value of three minimally invasive techniques:small bone window microsurgery,neuroendoscopic surgery and stereotactic drainage based on 12 randomized controlled trials(RCTs),7 cohort studies,and 8 economic evaluations 2019-2024.Cost-effectiveness analysis(CEA)and cost-utility analysis(CUA)were employed to assess resource utilization and health outcomes.Minimally invasive approaches overall outperform conventional craniotomy.Stereotactic surgery achieves the shortest hospitalization(5-8 days)and lowest direct costs;neuroendoscopy significantly improves quality of life(quality-adjusted life years(QALYs);and small bone window surgery offers the best postoperative stability.It is recommended to choose the surgical method based on patient characteristics and to optimize healthcare resource allocation through medical insurance payment reform and technology promotion.
